GBM4EPI | Development of glioblastoma and blood-tumour barrier models for investigating the combination therapy of anticancer agents and efflux pump inhibitors

Summary
"Glioblastoma (GBM) remains the most common malignant primary brain tumour with a median survival
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/101151942
Start date: 01-01-2025
End date: 31-12-2026
Total budget - Public funding: - 172 750,00 Euro
Cordis data

Original description

"Glioblastoma (GBM) remains the most common malignant primary brain tumour with a median survival

Status

SIGNED

Call topic

HORIZON-MSCA-2023-PF-01-01

Update Date

02-10-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon Europe
HORIZON.1 Excellent Science
HORIZON.1.2 Marie Skłodowska-Curie Actions (MSCA)
HORIZON.1.2.0 Cross-cutting call topics
HORIZON-MSCA-2023-PF-01
HORIZON-MSCA-2023-PF-01-01 MSCA Postdoctoral Fellowships 2023